Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7

Ellen Bolotin, Monika Smogorzewska, Susan M. Smith, +2

Blood

Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

Ellen Bolotin, Geralyn Annett, Robertson Parkman, +1

Bone Marrow Transplantation

TransplantationClinical CharacteristicsImmunologyHematologyStem Cell Transplantation +7

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

D. Ross Camidge, Jair Bar, Hidehito Horinouchi, +28

Journal of Clinical Oncology

Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy

Carolyn E. Behrendt, Joseph Rosenthal, Ellen Bolotin, +3

Biology of Blood and Marrow Transplantation

A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type <i>KRAS</i> who have received first‐line systemic therapy

Cathy Eng, Alberto Bessudo, Lowell L. Hart, +11

International Journal of Cancer

Kras Wild-typeMedicineFirst‐line Systemic TherapyMetronomic TherapyPharmacology +13

Transplant‐associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus

Joseph Rosenthal, Anna Pawłowska, Ellen Bolotin, +4

Pediatric Blood & Cancer

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children

Andrew D.J. Pearson, Nicole Scobie, Koen Norga, +36

European Journal of Cancer

Translational MedicinePediatric EpidemiologyMedicinePediatric HematologyMedicinal Product Development +9

Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank

Rachel D. Török, Jennifer S. Li, Prince J. Kannankeril, +31

Journal of the American Heart Association

Cardiovascular DiseaseMulti‐stakeholder Think TankPediatric Heart DiseasePediatricsMedicine +3

High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors

Joseph Rosenthal, Ellen Bolotin, Marianna Shakhnovits, +6

Bone Marrow Transplantation

Hematological MalignancyCell TherapyOncologyMedicineStem Cell Mobilization +8

A randomized, placebo-controlled, phase I/II study of tivantinib (ARQ 197) in combination with cetuximab and irinotecan in patients (pts) with <i>KRAS</i> wild-type (WT) metastatic colorectal cancer (CRC) who had received previous front-line systemic therapy.

Cathy Eng, Lowell L. Hart, A. Severtsev, +10

Journal of Clinical Oncology

Phase I/ii StudyPathologyPharmacotherapyOncologyGastrointestinal Oncology +14